000 | 01502 a2200433 4500 | ||
---|---|---|---|
005 | 20250514181932.0 | ||
264 | 0 | _c20040707 | |
008 | 200407s 0 0 eng d | ||
022 | _a0378-584X | ||
024 | 7 |
_a10.1159/000075611 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeinmann, M | |
245 | 0 | 0 |
_aTumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. _h[electronic resource] |
260 |
_bOnkologie _cFeb 2004 |
||
300 |
_a83-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCell Hypoxia _xgenetics |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHypoxia-Inducible Factor 1 |
650 | 0 | 4 | _aHypoxia-Inducible Factor 1, alpha Subunit |
650 | 0 | 4 |
_aNeoplasm Invasiveness _xgenetics |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aTranscription Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
700 | 1 | _aBelka, C | |
700 | 1 | _aPlasswilm, L | |
773 | 0 |
_tOnkologie _gvol. 27 _gno. 1 _gp. 83-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000075611 _zAvailable from publisher's website |
999 |
_c14727270 _d14727270 |